Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dresse Kim Q. Do, Centre Hospitalier Universitaire Vaudois
ClinicalTrials.gov Identifier:
NCT01506765
First received: January 3, 2012
Last updated: January 17, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)
No publications provided by Centre Hospitalier Universitaire Vaudois

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):